Intelligence Feed event · Equity · 2026-09-15

    Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant

    Question

    Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant

    Direct answer

    Health Catalyst announced the formal appointment of Simeon Kohl to lead the company as CEO and President, effective September 14, 2026. To secure the executive transition, the board granted 2,747,385 RSUs outside the standard shareholder-approved plan pursuant to Nasdaq Listing Rule 5635(c)(4). The equity package vests over a two-year window, with an initial 915,975 unit tranche, tying leadership compensation to medium-term operational execution in healthcare analytics.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-15
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant”, revision 1, evidence through 2026-09-15. https://marketontology.com/market-events/2026-09-15/health-catalyst-appoints-simeon-kohl-ceo-with-2-75m-inducement-share-grant-9beb1e

    EQUITY
    Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant
    Health Catalyst announced the formal appointment of Simeon Kohl to lead the company as CEO and President, effective September 14, 2026. To secure the executive transition, the board granted 2,747,385 RSUs outside the standard shareholder-approved plan pursuant to Nasdaq Listing Rule 5635(c)(4). The equity package vests over a two-year window, with an initial 915,975 unit tranche, tying leadership compensation to medium-term operational execution in healthcare analytics.
    HCAT
    Impact
    56
    SEP 15
    SIG
    90%
    HCAT
    Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant
    Health Catalyst announced the formal appointment of Simeon Kohl to lead the company as CEO and President, effective September 14, 2026. To secure the executive transition, the board granted 2,747,385 RSUs outside the standard shareholder-approved plan pursuant to Nasdaq Listing Rule 5635(c)(4). The equity package vests over a two-year window, with an initial 915,975 unit tranche, tying leadership compensation to medium-term operational execution in healthcare analytics.
    → Executive leadership transition and equity inducement vesting terms establish multi-year operational targets for healthcare data analytics provider HCAT.
    Impact
    Health Catalyst announced the formal appointment of Simeon Kohl to lead the company as CEO and President, effective September 14, 2026. To secure the executive transition, the board granted 2,747,385 RSUs outside the standard shareholder-approved plan pursuant to Nasdaq Listing Rule 5635(c)(4). The equity package vests over a two-year window, with an initial 915,975 unit tranche, tying leadership compensation to medium-term operational execution in healthcare analytics.
    Affected
    HCAT
    Transmission
    Executive leadership transition and equity inducement vesting terms establish multi-year operational targets for healthcare data analytics provider HCAT.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    HCATleadership succession and potential future share overhang from inducement grantMixed1-4wHealth Catalyst appointed Simeon Kohl CEO with 2,747,385 RSU grant.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month